Ameriprise’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-461,500
| Closed | -$55.6M | – | 4040 |
|
|
2023
Q1 | $55.6M | Sell |
461,500
-65,550
| -12% | -$7.9M | 0.02% | 699 |
|
|
2022
Q4 | $60.5M | Sell |
527,050
-50,000
| -9% | -$5.74M | 0.02% | 654 |
|
|
2022
Q3 | $59.5M | Hold |
577,050
| – | – | 0.02% | 631 |
|
|
2022
Q2 | $58.6M | Buy |
577,050
+259,800
| +82% | +$26.4M | 0.02% | 659 |
|
|
2022
Q1 | $37.5M | Sell |
317,250
-25,000
| -7% | -$2.95M | 0.01% | 934 |
|
|
2021
Q4 | $39.3M | Buy |
+342,250
| New | +$39.3M | 0.01% | 958 |
|
|
2020
Q4 | – | Sell |
-485,700
| Closed | -$54.3M | – | 3838 |
|
|
2020
Q3 | $54.3M | Buy |
485,700
+97,400
| +25% | +$10.9M | 0.02% | 603 |
|
|
2020
Q2 | $40.6M | Buy |
+388,300
| New | +$40.6M | 0.02% | 695 |
|